PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.14%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
1.82%
Cost growth less than half of CRWV's 19.16%. David Dodd would verify if cost advantage is structural.
2.18%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
0.04%
Margin expansion below 50% of CRWV's 1.30%. Michael Burry would check for structural issues.
20.55%
R&D change of 20.55% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.50%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
4.91%
Total costs growth less than half of CRWV's 18.28%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-5.71%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-3.39%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-0.91%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-3.10%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-5.13%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-65.12%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-7.60%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-9.54%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-8.67%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-7.07%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-9.02%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-12.50%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-12.50%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
6.44%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
6.44%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.